The PITX2 antibody is a crucial tool in developmental biology and disease research, targeting the Paired-like Homeodomain Transcription Factor 2 (PITX2). PITX2. a member of the bicoid-related homeodomain family, plays a pivotal role in embryonic development, particularly in establishing left-right asymmetry, cardiac morphogenesis, and ocular and craniofacial development. It regulates gene expression by binding to specific DNA sequences, influencing cell differentiation and tissue patterning. Mutations in the PITX2 gene are linked to Axenfeld-Rieger syndrome, characterized by eye abnormalities, dental defects, and cardiac malformations, as well as atrial fibrillation and certain cancers.
Researchers employ PITX2 antibodies to investigate its expression, localization, and functional roles in tissues and disease models. These antibodies are widely used in techniques like immunohistochemistry, Western blotting, and immunofluorescence to visualize PITX2 protein levels in developmental stages or pathological conditions. In cancer studies, PITX2’s dual role as either an oncogene or tumor suppressor, depending on context, makes its antibody valuable for profiling tumor subtypes and understanding metastasis. Additionally, it aids in exploring regenerative mechanisms and developmental pathways in model organisms. Commercial PITX2 antibodies are typically validated for specificity across human, mouse, and rat samples, ensuring broad applicability in translational research.